Analyst Ratings for Pacira Pharmaceuticals (PCRX)

PCRX Rating Summary

PCRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PCRX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $78.54 (+26.2%) * Over Last 12-Mos
Rating Score: 5 / 10   Percentile Rank: 50%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/9/2021 Berenberg Anita Dushyanth New Coverage Buy
(N/A)
93.00
(N/A)
68.50
(62.21)
-9.18% Details
4/7/2021 RBC Capital Daniel Busb New Coverage Outperform
(N/A)
86.00
(N/A)
68.89
(62.21)
-9.7% Details
Like PCRX Ratings? Also take a look at HRTX

PCRX Ratings News